Literature DB >> 26349839

Biomarkers, Risk Factors, and Risk: Clarifying the Controversy About Surrogate End Points and Clinical Outcomes.

Harlan M Krumholz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26349839      PMCID： PMC5322983          DOI： 10.1161/CIRCOUTCOMES.115.002245

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  16 in total

Review 1.  Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem.

Authors:  Rodney A Hayward; Timothy P Hofer; Sandeep Vijan
Journal:  Ann Intern Med       Date:  2006-10-03       Impact factor: 25.391

2.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

3.  Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT.

Authors:  John A Jarcho; John F Keaney
Journal:  N Engl J Med       Date:  2015-06-03       Impact factor: 91.245

4.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Authors:  H B Rubins; S J Robins; D Collins; C L Fye; J W Anderson; M B Elam; F H Faas; E Linares; E J Schaefer; G Schectman; T J Wilt; J Wittes
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

5.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

6.  Effects of combination lipid therapy in type 2 diabetes mellitus.

Authors:  Henry N Ginsberg; Marshall B Elam; Laura C Lovato; John R Crouse; Lawrence A Leiter; Peter Linz; William T Friedewald; John B Buse; Hertzel C Gerstein; Jeffrey Probstfield; Richard H Grimm; Faramarz Ismail-Beigi; J Thomas Bigger; David C Goff; William C Cushman; Denise G Simons-Morton; Robert P Byington
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

7.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

Review 8.  Mechanism of action of fibrates on lipid and lipoprotein metabolism.

Authors:  B Staels; J Dallongeville; J Auwerx; K Schoonjans; E Leitersdorf; J C Fruchart
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

9.  Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright
Journal:  N Engl J Med       Date:  2012-11-05       Impact factor: 91.245

10.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321
View more
  5 in total

Review 1.  Perceived Age as a Mortality and Comorbidity Predictor: A Systematic Review.

Authors:  Francisco R Avila; Ricardo A Torres-Guzman; Karla C Maita; John P Garcia; Clifton R Haider; Olivia A Ho; Rickey E Carter; Christopher J McLeod; Charles J Bruce; Antonio J Forte
Journal:  Aesthetic Plast Surg       Date:  2022-06-01       Impact factor: 2.326

2.  Does Nonsurgical Periodontal Treatment Improve Systemic Health?

Authors:  H L Taylor; S Rahurkar; T J Treat; T P Thyvalikakath; T K Schleyer
Journal:  J Dent Res       Date:  2020-10-22       Impact factor: 6.116

Review 3.  Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review.

Authors:  Alison M Pease; Harlan M Krumholz; Nicholas S Downing; Jenerius A Aminawung; Nilay D Shah; Joseph S Ross
Journal:  BMJ       Date:  2017-05-03

4.  An Uninformative Truth: The Logic of Amarin's Off-Label Promotion.

Authors:  Spencer Phillips Hey; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2016-03-15       Impact factor: 11.069

5.  The Failure to Measure Dietary Intake Engendered a Fictional Discourse on Diet-Disease Relations.

Authors:  Edward Archer; Carl J Lavie; James O Hill
Journal:  Front Nutr       Date:  2018-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.